HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Open trial of fluoxetine in children and adolescents with dysthymic disorder or double depression.

AbstractBACKGROUND:
Chronic depressions commonly present in youth and cause significant morbidity. No treatment studies in this age group are currently available.
METHODS:
19 pediatric subjects with dysthymic disorder or 'double depression' were recruited. After four weeks of psychosocial treatment, subjects failing to improve began open treatment with fluoxetine (20 mg) for eight weeks. Subjects were then reassessed for treatment response.
RESULTS:
Fifteen subjects entered the medication phase, and eleven (73%) no longer met criteria for dysthymic disorder or Major Depression at final assessment.
CONCLUSIONS:
Fluoxetine shows promise as a safe and effective treatment for youth with chronic depressions. Controlled trials are indicated.
LIMITATIONS:
Open label design, no comparison treatment condition.
CLINICAL RELEVANCE:
As in adults, treatment with antidepressants may prove to be a useful intervention with children and adolescents with chronic forms of depression.
AuthorsB D Waslick, B T Walsh, L L Greenhill, M Eilenberg, L Capasso, D Lieber
JournalJournal of affective disorders (J Affect Disord) Vol. 56 Issue 2-3 Pg. 227-36 (Dec 1999) ISSN: 0165-0327 [Print] NETHERLANDS
PMID10701482 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antidepressive Agents, Second-Generation
  • Fluoxetine
Topics
  • Adolescent
  • Antidepressive Agents, Second-Generation (pharmacology, therapeutic use)
  • Child
  • Dysthymic Disorder (drug therapy, psychology)
  • Female
  • Fluoxetine (pharmacology, therapeutic use)
  • Humans
  • Male
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: